| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Equillium, Inc. | Director | Director Stock Option (right to buy) | 20K | 21 May 2025 | Direct | ||
| Checkmate Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EQ | Equillium, Inc. | 21 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 13:50 |
| EQ | Equillium, Inc. | 11 Dec 2024 | 1 | $0 | 4 | Director | 12 Dec 2024, 17:45 |
| EQ | Equillium, Inc. | 11 Dec 2024 | 0 | $0 | 3 | Director | 12 Dec 2024, 17:43 |
| CMPI | Checkmate Pharmaceuticals, Inc. | 31 May 2022 | 2 | $0 | 4 | Director | 31 May 2022, 10:08 |
| CMPI | Checkmate Pharmaceuticals, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 21:18 |